RELIAJECT Trademark

Trademark Overview

On Thursday, June 17, 2010, a trademark application was filed for RELIAJECT with the United States Patent and Trademark Office. The USPTO has given the RELIAJECT trademark a serial number of 85065631. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2013. This trademark is owned by Ranbaxy Pharmaceuticals Inc.. The RELIAJECT trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery apparatus, namely, automatic injector for delivering pharmaceuticals, in the treatment of anaphylactic shock with epinephrine, nerve gas with various antidotes, pain management with drugs such as morphine, the treatment of migraines with drugs such as sumatriptan and other treatments of ailments not in the neurological field
reliaject

General Information

Serial Number85065631
Word MarkRELIAJECT
Filing DateThursday, June 17, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2011

Trademark Statements

Goods and ServicesDrug delivery apparatus, namely, automatic injector for delivering pharmaceuticals, in the treatment of anaphylactic shock with epinephrine, nerve gas with various antidotes, pain management with drugs such as morphine, the treatment of migraines with drugs such as sumatriptan and other treatments of ailments not in the neurological field
Pseudo MarkRELIABLE INJECTOR

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 21, 2010
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRanbaxy Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJacksonville, FL 32257
Party NameRanbaxy Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJacksonville, FL 32257

Trademark Events

Event DateEvent Description
Monday, June 17, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 17, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 19, 2012EXTENSION 3 GRANTED
Wednesday, November 14, 2012EXTENSION 3 FILED
Wednesday, November 14, 2012TEAS EXTENSION RECEIVED
Wednesday, June 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2012EXTENSION 2 GRANTED
Wednesday, May 16, 2012EXTENSION 2 FILED
Tuesday, June 12, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 16, 2012TEAS EXTENSION RECEIVED
Wednesday, November 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2011EXTENSION 1 GRANTED
Monday, November 7, 2011EXTENSION 1 FILED
Monday, November 7, 2011TEAS EXTENSION RECEIVED
Tuesday, May 17, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, February 15, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, February 15, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, October 1, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 1, 2010NON-FINAL ACTION E-MAILED
Friday, October 1, 2010NON-FINAL ACTION WRITTEN
Friday, September 24, 2010ASSIGNED TO EXAMINER
Tuesday, July 20, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 20, 2010ASSIGNED TO LIE
Thursday, July 8, 2010TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, June 22, 2010NOTICE OF PSEUDO MARK MAILED
Monday, June 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 21, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

reliaject treatment such drugs pain morphine management migraines sumatriptan neurological field